Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Other Non-Current Assets (2016 - 2025)

Arcadia Biosciences filings provide 12 years of Other Non-Current Assets readings, the most recent being $92000.0 for Q1 2025.

  • On a quarterly basis, Other Non-Current Assets fell 43.9% to $92000.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $92000.0, a 43.9% decrease, with the full-year FY2024 number at $96000.0, down 97.24% from a year prior.
  • Other Non-Current Assets hit $92000.0 in Q1 2025 for Arcadia Biosciences, down from $96000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $3.5 million in Q4 2023 to a low of $23000.0 in Q1 2021.
  • Median Other Non-Current Assets over the past 5 years was $165500.0 (2022), compared with a mean of $352187.5.
  • Biggest five-year swings in Other Non-Current Assets: soared 14366.67% in 2023 and later crashed 97.24% in 2024.
  • Arcadia Biosciences' Other Non-Current Assets stood at $180000.0 in 2021, then tumbled by 86.67% to $24000.0 in 2022, then soared by 14366.67% to $3.5 million in 2023, then crashed by 97.24% to $96000.0 in 2024, then decreased by 4.17% to $92000.0 in 2025.
  • The last three reported values for Other Non-Current Assets were $92000.0 (Q1 2025), $96000.0 (Q4 2024), and $212000.0 (Q2 2024) per Business Quant data.